GLP-1 medications are reshaping global consumer appetite, and new research by MMR across five countries reveals surprising shifts. Andrew and Caitlin explore why brands across food, drink, beauty and wellness can no longer treat this as a niche, temporary trend.
The rules of appetite just changed - and so has the shopping basket.
In this episode, Andrew and Caitlin unpack exclusive new MMR research across 3,000 consumers in the US, UK, Germany, Brazil and China to reveal how GLP-1 medications are rewiring global demand. From the surprising sales surge in premium chocolate to the rise of "denser pleasure" formats, we explore what happens when immediate gratification stops being the default - and why food, drink, beauty and wellness brands can no longer treat this as a niche, temporary trend.
Featuring WGSN's Millie Diamond on the strategic opportunities behind premium small bites, plus a first listen to our companion debate on just how big this story could get.
Credits
Hosts: Andrew Wardlaw, Caitlin McLean
Executive Producer: Alex Berteanu
Production
Ideal Insight
Social Media
Palesa Mthiyane
Publicity
Camargue